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METZGER, B. L. AND B. C. HANSEN. Cholecystokinin effects on feeding, glucose, and pancreatic hormones in rhesus 
monkeys. PHYSIOL BEHAV 30(4)509-518, 1983.--The effects of cholecystokinin on feeding, and on plasma glucose and 
pancreatic hormone responses to a mixed-meal were determined in lean rhesus monkeys. Following an overnight fast the 
octapeptide of cholecystokinin (CCK-8) was administered intravenously over a 6 minute period coincident with the 
initiation of free feeding or an intragastric infusion of a mixed liquid diet. CCK-8 inhibited feeding and delayed the plasma 
glucose and insulin response to a mixed-meal. The threshold for the feeding effect ranged from 30 to 120 ng/kg/min across 
monkeys and did not extend beyond 15 minutes of the start of the CCK infusion. The delays in plasma glucose and insulin 
were not dependent on rate or amount of food entering the stomach. Further, there were no alterations from basal levels in 
plasma glucose or insulin prior to the onset of CCK-induced feeding inhibition. There was no evidence that CCK-8 
stimulated insulin release, nor was the usual close relationship between plasma glucose and insulin levels in response to a 
mixed-meal changed by CCK-8. 
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PERIPHERAL intravenous infusions of the exogenous syn- 
thetic octapeptide of the brain-gut peptide, cholecystokinin 
(CCK-8) have been shown to suppress feeding in many 
animal species, including man [1, 3, 6, 9, l 1, 26]. In general, 
this reduction in intake is food-specific and free of apparent 
clinical and sub-clinical distress [1, 3, 6, I1, 12]. The degree 
of feeding suppression appears to be dependent upon multi- 
ple factors, including the amount of CCK infused and the 
length of the infusion, as well as the length of the food depri- 
vation period preceding each experiment [21,26]. With few 
exceptions, the nature of the CCK-induced feeding effect has 
been described as a rapid, but limited decrease in the length 
of the meal [l, 6, 9, 11]. In hungry pigs, Anika, Houpt and 
Houpt demonstrated a rapid threshold type on-off interrup- 
tion of a meal [1]. CCK did not alter the initial feeding rate in 
rats o r m a n  [9, 11, 21]. 
The present study examined the effect of short duration 
intravenous infusions of CCK-8, at varying doses, on the 
feeding behavior of rhesus monkeys using a feeding system 
which allows precise monitoring of food intake and pattern. 
We also sought further clarification of CCK-8's effects on 
the endocrine pancreas. Jensen and associates [10] were un- 
able to stimulate insulin or glucagon release from an isolated 
pancreas preparation with CCK-8 infused within probable 
physiological levels. On the other hand, Rouiller and others 
[23] using intact, anesthetized dogs, administered intrave- 
nous CCK-8 and observed increased pancreatic vein and in- 
ferior vena cava levels of plasma insulin and glucagon. An 
indirect role of CCK could be associated with the pre- and 
post-absorption alterations in the plasma levels of glucose 
and insulin which have been purported to play significant 
roles in moment to moment appetite regulation [14]. In addi- 
tion to the reported effects on plasma glucose and insulin, 
exogenous CCK-8 has been found to significantly elevate 
pancreatic polypeptide levels [15]. Further, McLaughlin and 
Baile [17] have demonstrated that intraperitoneal injections 
of the pancreatic polypeptide decreased food intake in lean 
mice. 
The present experiments in monkeys examined the ef- 
fects of intravenous CCK-8 on the levels of plasma glucose, 
insulin, glucagon, and pancreatic polypeptide in response to 
an oral or intragastrically infused mixed meal. Furthermore, 
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these experiments sought to identify any association be- 
tween effects of CCK-8 on feeding behavior and the changes 
across time in mixed-meal stimulated plasma levels of glu- 
cose and pancreatic hormones. 
METHOD 
Five young adult male rhesus monkeys (Macaca mulatta) 
weighing from six to nine kg were studied. The monkeys 
were accustomed to three-tiered primate restraint chairs and 
were housed in a temperature controlled room (22°C) with a 
12-hour light/dark cycle (lights on at 0700 hr). Each monkey 
was accustomed to an eight hour/day feeding regimen (0800 
to 1600 hours), and a completely balanced liquid diet 
(Ensure ©, Ross Laboratories) which contains 1.06 kcal/ml 
with 14% of the calories as protein, 31.5% fat, and 54.5% 
carbohydrate.  The liquid diet was delivered via a sucking- 
activated automated feeding system designed to provide 
each monkey with free access to food during the daily eight 
hour feeding period, while at the same time permitting mi- 
crocomputer recording of detailed patterns of  ingestion [25], 
including meal size (kcal), meal duration (seconds), and 
inter-meal interval (minutes). Each meal was defined as a 
period of sustained feeding (minimum amount 20 kcal) sepa- 
rated from the next such period by at least five minutes, and 
the period of separation was defined as the inter-meal inter- 
val (IMI). Water was available ad lib, 24 hr/day. 
Following adaptation to the laboratory, restraint, liquid 
diet and feeding system, each monkey was surgically im- 
planted with silastic intravenous and intragastric cannulas. 
The intravenous cannulas (1 mm ID, 2.2 mm OD) were in- 
serted into the internal or external jugular veins, and passed 
so that the tips were located in the superior vena cava, just 
above the atrium, or were inserted via the femoral veins to 
the inferior vena cava. Two intravenous cannulas were used 
to allow simultaneous infusion and withdrawal. The cannulas 
were kept patent by continuous infusion of heparinized 
isotonic saline (4 U/ml) at a rate between 25-50 ml/24 hour 
period. An intragastric cannula (1.2 mm ID, 2.4 mm OD) was 
placed in the body of the stomach. Following surgery, all 
experiments were delayed until the animal resumed feeding 
at levels approximating those preceding surgery. 
In all experiments the synthetic sulphated C-terminal oc- 
tapeptide of cholecystokinin (CCK-8) (Kinevac, Squibb) was 
mixed with distilled water to a concentration of 1 /xg/ml. 
Each experimental dose was mixed with an isotonic saline 
carrier to equalize the volumes infused, and the flow rate of a 
Harvard pump was adjusted to infuse the solution at a con- 
stant rate of 4.75 ml/min. Saline controls of equal volume 
were infused at the same rate. Each infusion lasted exactly 
six minutes. CCK doses ranged from 15 to 120 ng/kg/min, 
and were administered in random order, with all experiments 
conducted on separate days. 
The plasma glucose, insulin (IRI), glucagon (IRG) and 
pancreatic polypeptide (PP) responses to six minute intrave- 
nous (IV) infusions of CCK-8, administered simultaneously 
with either the initiation of free feeding or the initiation of an 
intragastrie mixed-meal infusion, were determined. The time 
courses of these responses were followed from immediately 
prior to the start of the CCK-8 infusion (following a 16-hour 
overnight fast) to 120 minutes. Blood samples were with- 
drawn immediately before and at intervals of 5, 10, 20, 30, 
40, 60 and 120 min from the start of the mixed meal challenge 
and IV infusion of CCK. Two milliliters of a mixture of blood 
and heparin solution were withdrawn to clear the cannula 
dead space followed by the removal of blood samples of 
three ml each. The dead space fluid was returned to the 
animal after each sample was withdrawn. Blood samples 
were placed in ice in sterile heparinized tubes and cen- 
trifuged at 2000 RPM for six minutes, within 20 minutes of 
the draw. The plasma was aliquoted into appropriate assay 
and storage tubes and frozen at -20°C. The residual blood 
cells were maintained in sterile containers, reconstituted 
with bacteriostatic saline and returned to the monkey at the 
completion of each study. Plasma levels of glucose were 
measured by the hexokinase and glucose-6-phosphate dehy- 
drogenase method of Slein [24]. Double-antibody radioim- 
munoassays were used to determine plasma IRI [8], IRG [22] 
and PP [4] levels. 
Monkeys were not disturbed during the sample collection 
period and were observed systematically every three min- 
utes for three seconds through a one-way mirror during the 
first 45 minutes of the experimental period. Behavioral rating 
scales were used to record these observations, and included 
sleeping, resting, drinking, eating, sickness behavior and 
non-ingestive activity. Sleeping behavior was defined as no 
observable movement, head back and relaxed, and eyes 
closed; resting as no observable movement,  head back and 
eyes partially closed; feeding as sucking or licking food spout; 
drinking as licking or sucking water spout; sickness be- 
havior as restlessness, irritability, retching or vomiting; and 
non-ingestive activity as any movement of the body, arms, 
hands, head or eyes not related to feeding, drinking or sick- 
ness behavior. 
In the first set of experiments,  the six minute infusion of 
CCK-8 was started simultaneously with the start of volun- 
tary feeding of the first meal following the usual 16-hour 
overnight fast. Feeding behavior and plasma glucose, IRI, 
IRG and PP levels were monitored. In order to examine the 
CCK-8-induced changes in plasma levels of glucose and pan- 
creatic hormones following a mixed meal independent of the 
effects of CCK-8 on feeding behavior, a second series of 
experiments used controlled intragastric infusions of the 
same liquid diet as was taken orally in the first experiments. 
The liquid diet was infused at a rate of 10 ml/min for 10 rain 
(100 kcal total), and plasma levels of glucose, IRI, IRG, and 
PP were determined at intervals up to 120 min. Consistency 
between the oral and intragastric studies was maintained by 
initiating the intragastric infusion of the mixed-meal chal- 
lenge concurrently with the start of the intravenous infusion 
of CCK or saline immediately at the end of the monkey's  
accustomed 16-hour overnight fast. 
A univariate, one-sample t-test which allows the testing of 
the mean of a single sample of observations against an a 
priori value, (in this case baseline control feeding behavior) 
was used to describe the within-monkey differences in feed- 
ing behavior associated with CCK-8 infusion. For  descrip- 
tive purposes each feeding parameter (meal size, meal dura- 
tion. IMI length and total daily intake) for each animal, and 
CCK experiment,  was substituted for the a priori value and 
compared to a control mean derived from a sampling of the 
same animal 's usual daily eating data (N =9 days). One way 
analysis of variance (ANOVA) was used to estimate the 
across monkey differences in feeding behavior as a function 
of CCK infusions. When significant experimental effects oc- 
curred, Scheffe's contrast method was used to identify the 
specific ways in which the experimental effects contributed 
to the overall F-ratio [7]. This procedure included the use of 
protected paired t-tests with a 0.95 Scheffe allowance which 
compensate for the inflated alpha associated with multiple 
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t-tests. Only the results of the protected t-tests are reported 
unless otherwise noted. Protected paired t-tests were also 
used as a basis for describing more specific effects of  CCK 
on plasma glucose, IRI, IRG and PP. Because there were 
significant between-animal differences in basal levels, the 
basal level of  each peptide or substrate was subtracted from 
each subsequent value collected over the 120-minute sam- 
pling period, thus identifying the total increment above basal 
levels for each parameter  at each time point. Total response 
area for each parameter  from 0 to 120 min was also calcu- 
lated and the above mentioned analysis procedure using 
ANOVA and protected paired t-tests was used to identify 
differences in response areas compared to saline controls. 
Glucose and insulin values were standardized to permit 
further analysis of changes in the insulin/glucose ratio across 
time and across various CCK-8 doses. The significances of 
differences in these ratios between CCK doses across 
animals were determined for each time point by protected 
paired t-tests. Finally, the initial overall within-animal glu- 
cose, insulin, glucagon and pancreatic polypeptide response 
to the mixed meal stimulus across experimental conditions 
was determined by profile analysis techniques. Because 
the obvious differences in the hormones and glucose re- 
sponses occurred within the first 40 minutes of  the experi- 
ment, analysis focused on the time period 0-40 minutes. 
Profile analysis allows the separate testing of  (a) the differ- 
ences between the overall plasma response curves across 
time for all 4 doses of  CCK and saline controls, (b) the differ- 
ences in the shapes of the response curves (parallelism), and 
(c) the hypothesis that the curves are flat (plasma levels do 
not change across time) [7]. 
RESULTS 
CCK-8 Effect on Feeding Behavior 
CCK-8, administered intravenously during the first six 
minutes of a meal following an overnight fast, has an im- 
mediate and significant effect on intrameal pattern at the 
lowest doses tested (30 ng/kg/min) and temporarily causes 
cessation of  feeding at the highest dose (120 ng/kg/min) in all 
monkeys studied. The minimal six minute infusion dose re- 
quired to terminate an ongoing meal following an overnight 
fast differed between monkeys, ranging from 30 to 120 
ng/kg/min. 
As shown in Fig. 1, the usual size of  the first meal follow- 
ing an overnight fast in these monkeys ranged from 227 to 
281 kcal. The infusion of CCK-8 at a dose of 30 ng/kg/min 
had no effect on meal size in 3 of  4 monkeys, and maximal 
suppressive effect in the fourth monkey. An infusion level of  
60 ng/kg/min produced near maximal effects on meal size in 
all but one monkey; the latter required 120 ng/kg/min to 
produce the cessation of  ingestion during the course of a 
meal. Further,  all animals stopped eating within 2 minutes 
when CCK was infused at a rate of 120 ng/kg/min. In general, 
meal sizes below 60 kcal reflect the intake during the first 1-2 
min of the availability of  food. Since CCK-8 infusions were 
begun simultaneously with the onset of  feeding, the CCK 
effect was not apparent in truncating the ongoing meal until 
1-2 min into the feeding period. Thus, for all monkeys,  the 
minimal dose which affected meal size produced a maximal 
or near maximal reduction in meal size, indicating the abrupt 
onset of the CCK effect. 
Reduction in the duration of the test meal was more sen- 
sitive to the effect of  CCK, with significant decreases in meal 
length observed usually at 30 and always at 60 ng/kg/min; 
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* P<.05 that meal size is < controls 
FIG. 1. Effect of a 6 min intravenous infusion of CCK-8 at three 
dose levels on meal size (kcal), compared to control or saline infu- 
sion conditions following an overnight fast. 
further increase in dose resulted in even greater reduction in 
meal duration: t (16)=-4 .9 ,  p<0.001 (Table 1). 
The cumulative intakes for one monkey (B-6) at each of 
three doses of  CCK-8 and under saline control conditions are 
shown in Fig. 2A. Both changes in first meal size and in 
pattern of  feeding are apparent at doses of 60 and 120 
ng/kg/min. It is apparent from this figure for a single repre- 
sentative animal, that the rate of  feeding was not affected 
within any single feeding bout, but longer periods of  rest or 
interruptions in feeding were clearly observed. Furthermore,  
when early interruptions of  feeding occurred, the amount 
taken during the first 40 minutes was reduced (Fig. 2A). 
Across monkeys when a meal was either terminated or 
reduced by CCK-8 infusion, the subsequent inter-meal inter- 
val (IMI) was very shor t - - less  than 35% of the normal IMI 
duration for each monkey, or an actual IMI of only 6 to 20 
min compared to the usual control IMI (mean±SE)  of 
155± 16 min (Table 1). The amount ingested in the meal im- 
mediately following the CCK-8-induced interruption of feed- 
ing, when added to the initial feeding amount prior to the 
onset of the CCK effect, 218__-15 kcal (mean__+SE), generally 
approximated the total consumed in the usual first meal 
under control conditions (251±14 kcal): t (8 )= -2 .2 ,  p = n s .  
Within the first three hours following the six minute CCK-8 
infusion, most animals initiated a second meal, as was their 
usual pattern, and the food intake had returned to within 
normal levels for that time period (control=326± 16 kcal as 
compared to 300± 17 kcal), thus reinforcing the finding of an 
extremely transient effect of  intravenous CCK-8. Total day ' s  
intake, and the intake of  the subsequent day showed no ef- 
fect of the short-term CCK-8 infusion compared to saline 
controls. 
In summary, the dose of  CCK-8, over a range of 30 to 120 
ng/kg/min infused for a six minute period was negatively 
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TABLE 1 
EFFECTS OF VARYING DOSES OF CCK-8 ON THE SIZE OF THE FIRST MEAL, ITS DURATION, THE RATE OF INTRA-MEAL 
FEEDING, AND THE DURATION OF THE CCK INDUCED INTERRUPTION IN FEEDING 
Duration of 
Size of Length of Feeding rate first inter-meal 
*CCK-8 Dose first meal first meal during first meal interval 
Monkey (ng/kg/min) (% of control) (% of control) (ml/sec) I% of control) 
B-6 120 5t 3t 0.44 6t 
C-6 120 17+ 9 + 0.33 10+ 
G-6 120 21t 10t 0.56 l i t  
Y-5 120 14t 8t 0.46 34t 
mean ± SE - -  14 ± 3% 8 ± 2% 0.45 ± 0.05 16 ± 06~ 
B-6 60 16+ 23t 0.20 2+ 
C-6 60 104 75t 0.25 83 
G-6 60 22t 24t 0.25 8t 
Y-5 60 l i t  6+ 0.50 24t 
mean ± SE - -  38 ± 22% 32 ± 15% 0.30 ± 0.07 30 ± 18~ 
B-6 30 110 86 0.37 $ 
C-6 30 81 44+ 0.33 128+ 
G-6 30 99 72+ 0.37 76 
Y-5 30 l l t  16+ 0.18 16t 
mean ± SE - -  75 ± 22% 55 ± 16% 0.31 ± 0.50 73 ± 32% 
*The duration of each CCK-8 intravenous infusion was 6 minutes. 
tp<0.05 when data points are compared with each animals own usual feeding pattern, by a one sample t-test. 
SData missing. 
correlated with the size of the first meal: t (16)=-4.2 ,  
p<0.001, the duration of the first meal: t (16)=-4.9 ,  
p<0.001, and the duration of the first inter-meal interval: 
t (15)=-2.5 ,  p<0.03, but had no significant relationship to 
total food intake for the test day nor for the subsequent day. 
CCK-8  E f f ec t  on P l a s m a  Glucose  R e s p o n s e  to a M i x e d  Mea l  
As can be seen in Fig. 2B and 2C for one representative 
animal, CCK-8, infused at rates of 30-120 ng/kg/min, 
produced an obvious delay in the usual rise in plasma glu- 
cose and insulin in response to the oral ingestion of a mixed 
meal. These delays occurred in both free-feeding animals 
tested. Because CCK-8 administered during free feeding, as 
described above, truncated the initial meal, the attentuated 
glucose and insulin rises could have been associated with the 
reduced size of the meal load. In order to assess the effect of 
CCK on glucose and hormone responses to a mixed meal, 
independent of the effects on feeding behavior and the asso- 
ciated altered intake levels, the same diet, as was normally 
ingested orally, was infused directly into the stomach via an 
intragastric tube. A constant volume (100 ml or approx- 
imately 100 kcal) was infused at a rate of 10 ml/min. Because 
some effects on free feeding occurred at CCK-8 infusion 
levels as low as 30 ng/kg/min, subsequent studies of the ef- 
fects of CCK-8 on glucose and hormone responses to an 
intragastric mixed-meal load included a lower dose, 15 
ng/kg/min. 
Under these conditions of controlled amount and rate of 
intragastric mixed-meal challenge, CCK-8 still produced ap- 
parent delays in the stimulated plasma glucose rise when 
compared to saline-infused controls (Fig. 3). During the first 
40 minutes of the experiment, profile analysis revealed a 
significant CCK effect on the plasma glucose response to the 
intragastric infusion of a mixed meal. This effect was limited 
to comparisons between saline controls and CCK infused at 
the rates of 60 and 120 ng/kg/min, F(2,6)=5.7, p<0.05. 
ANOVA and protected t-tests revealed that at the 10 min 
point plasma glucose response rise was lower for CCK-8 
doses of 30, 60 and 120 ng/kg/min compared to saline con- 
trols, F(4,15)=4.3, p<0.02; however, protected t-tests 
demonstrated that only the difference between saline con- 
trols and 120 ng/kg/min exceeded the Scheffe allowance. By 
the 20 rain and 30 min time points glucose levels had returned 
toward saline control levels, and were significantly lower 
only at 20 rain for the 120 ng/kg/min dose, t(8)= I 1.8,p<0.01, 
and by 40 min, no CCK-8 effect on plasma glucose was sig- 
nificant. 
Overall plasma glucose response, based on integration of 
the glucose levels under the response curve for zero to 120 
minutes, was not affected by the 15, 30 or 60 ng/kg/min doses 
(Fig. 4). Because of the delayed onset of the glucose re- 
sponse, and the lack of full return to baseline levels by the 
120 rain point at the 120 ng/kg/min dose, the glucose re- 
sponse area was significantly smaller than normal saline con- 
trois, t(10)=2.9, p<0.02. 
CCK-8  Ef fec t  on P l a s m a  lnsul in  R e s p o n s e  to a M i x e d  Mea l  
As with plasma glucose, and shown in Fig. 2C for one 
representative animal, there were delays in the plasma IRI 
response to intravenous CCK-8 in free-feeding monkeys 
(N=2). When amount of the meal challenge and rate of de- 
livery were controlled by intragastric infusion of  the liquid 
diet, instead of  oral feeding, a similar delay in plasma insulin 
response was observed (Fig. 5). Profile analyses revealed a 
CCK effect on insulin response rise which approached signif- 
icance when saline controls and CCK-8 infused at the rates 
of  60 and 120 ng/kg/min were compared, F(2,6)=4,5, 
p -<0 .06 .  ANOVA demonstrated these differences occurred 
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FIG. 2A. Cumulative diet intake (kcal) during the first 40 min of free 
feeding following an overnight fast for a single representative animal 
(Monkey B-6). Varying doses of CCK-8 were infused during the first 
6 min only. The period of infusion is shown by the stippled area. 
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FIG. 2B. Plasma glucose response (rise above baseline level) to 6 
rain infusions of saline (control) and varying doses of CCK-8 during 
the free feeding experiment shown in Fig. 2A for a single represen- 
tative animal (Monkey B-6). The period of infusion is shown by the 
~tippled area. 
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FIG. 2C. Plasma insulin response (rise above baseline level) to 6 min 
infusions of saline (control) or varying doses of CCK-8 during the 
free feeding experiment shown in Fig. 2A for a single representative 
animal (Monkey B-6). The period of infusion is shown by the stip- 
pled area. 
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IG MIXED MEAL AND CCK 
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FIG. 3. Plasma glucose change from baseline (overnight fasted) 
levels during the following 10 min intragastric infusion of a mixed 
meal. CCK-8 was infused intravenously over a 6 min period at four 
dose levels (N =4 monkeys). The period of CCK infusion is indicated 
by the stippled area, and the period of the intragastric infusion by the 
dashed area at the bottom. 
at the 10 and 20 min time points; but when all possible pair 
combinations were contrasted only the difference between 
saline controls and CCK infused at 120 ng/kg/min at the 20 
min point was significant, t(8)=6.5, p<0.03. This difference 
did not, however, exceed the Scheffe allowance at the 0.95 
level. One change observed in the IRI response did not paral- 
lel the changes observed in plasma glucose: following CCK 
infused at the highest dose (120 ng/kg/min) at the 10 min time 
period, the mean IRI level of 48.1 IzU/ml was significantly 
lower than mean basal IRI levels of 67/xU/ml, t (8 )=-2 .4 ,  
p <0.05. By contrast, the 15 ng/kg/min dose produced a slight 
(non-significant) delay in rise of plasma insulin level at the 5 
min point, and possibly enhanced the plasma insulin re- 
sponses at 10, 20 and 30 min compared to normal saline 
controls (Fig. 5), 
As with glucose, the total insulin response (area under the 
curve-zero to 120 min) was reduced only by the 120 
ng/kg/min dose, t(10)=2.6, p<0.05, and this appeared to be 
an artifact of the duration of sampling and the lack of sam- 
ples between the 60 and 120 min time points, when the de- 
layed peak insulin values were undoubtedly reached (Fig. 4). 
The ratio of the standardized values for plasma insulin 
and plasma glucose showed no significant differences during 
the 120 min for any CCK-8 dose compared to a normal saline 
infusion. CCK-8 clearly did not disrupt the close association 
of plasma glucose and insulin in response to a mixed meal; 
there was even a slight tendency for CCK-8 at 120 ng/kg/min 
to strengthen the insulin-glucose relationship, relative to 
OVERALL GLUCOSE AND PANCREATIC HORMONE 
RESPONSE TO A MIXED MEAL AND IV CCK 
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:~ P<05 when compared to saline control levels 
FIG, 4. Total integrated response area of plasma glucose, insulin, 
glucagon and pancreatic polypeptide during the first 120 min follow- 
ing simultaneous initiation of 10 min intragastric mixed meal infu- 
sions and 6 rain intravenous CCK-8 infusions at four dose levels 
compared to saline control infusions (N=5 monkeys). 
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FIG. 5. Plasma insulin changes from baseline (overnight fasted) 
levels following l0 rain mtragastric infusion of a mixed meal and 
simultaneous 6 min intravenous infusion of four dose levels of 
CCK-8. The periods of the respective infusions are shown by stip- 
pled and dashed areas (N =4 monkeys). 
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FIG. 6. Plasma glucagon changes from baseline levels following 10 
min intragastric infusion of a mixed meal with simultaneous intrave- 
nous infusion of four different doses of CCK-8 during the first 6 min 
(N=4 monkeys). The periods of the respective infusions are shown 
as in Fig. 5. 
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FIG. 7. Plasma pancreatic polypeptide changes from baseline levels 
during and following l0 rain intragastric mixed meal infusion and 6 
min intravenous infusion of four doses of CCK-8 compared to saline 
infusions (N=4 monkeys). Period of the respective infusions are 
shown as in Fig. 5. 
ratios at 15 ng/kg/min or during saline controls. As shown in 
Table 2, plasma glucose and insulin levels were highly corre- 
lated at all CCK-8 dose levels. 
CCK-8 Effect on Plasma Glucagon and Pancreatic 
Polypeptide Responses to a Mixed Meal 
A six min intravenous infusion of CCK-8 had no consis- 
tent effect on the response of either plasma glucagon or pan- 
creatic polypeptide to intragastric infusion of  a mixed meal 
(Figs. 6 and 7). While levels of both hormones were generally 
higher during CCK-8 infusions, no consistent dose-related 
effects were observed. Only the 15 ng/kg/min dose produced 
a significant increase in plasma glucagon--and then only at 
the 10 min time point. Large variability was observed in 
these hormone responses. 
Non-Feeding Behavior: Effect o f  CCK-8 
Clinical signs of illness during the CCK-8 infusions were 
not observed. The monkeys showed no retching, vomiting, 
agitation, unusual drowsiness, or change in stool number or 
consistency• Maximal likelihood tests of independence 
demonstrated no CCK-8 dependent differences in behavior 
between the oral free feeding and the intragastric diet infu- 
sion conditions, except for the 120 ng/kg/min dose: the mon- 
keys engaged in significantly more resting behavior at this 
CCK dose level under the free feeding condition than under 
TABLE 2 
I N T E R A C T I O N  B E T W E E N  P L A S M A  G L U C O S E  A N D  I N S U L I N  
R E S P O N S E S  T O  A N  I G  I N F U S I O N  O F  A M I X E D  M E A L  A N D  S I X  
MINUTE IV INFUSIONS OF CCK-8* 
CCK Dose (ng/kg/min) 
Monkey saline 15 30 60 120 
C-6 .82t .74t .93¶ .90¢ .79¢ 
V-5 .76t - -  .97¶ .97¶ .96§ 
Y-5 .77t .855 .94§ .94¢ .99¶ 
G-6 .905 .87~ .97¶ .89¢ .93¢ 
Mean .81t .825 .95¶ .92¢ .925 
*All interactions are expressed as a product-moment correlation 
coefficient. 
tp<0.05, :~p<0.01, §p<0.001 and ¶p<0.0001 when the strength of 
the product-moment correlation coefficient is tested by the 
t-statistic. 
the intragastric diet infusion condition. Monkeys were, in 
fact, generally more active during the intragastric infusion 
than while free feeding. There were no other CCK- 
associated effects on non-ingestive behavior during the 45- 
minute observation period. 
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DISCUSSION 
Intravenous administration of CCK-8 over a 6 min period 
coincident with the initiation of free feeding following an 
overnight fast resulted in a dose-related cessation of the on- 
going meal. The threshold for this effect ranged from 30 to 
120 ng/kg/min across monkeys, and was apparent within 2 
rain of the start of the infusion. In a similar protocol using 
solid food ingestion by monkeys as the test parameter,  
Gibbs, Falasco, and McHugh [6] also reported significant 
suppression of feeding (a 66% decrease) using a dose of CCK 
slightly larger than our largest dose. Their assessment of 
feeding behavior was, however, limited to total amount of 
food taken at the 15, 30, 60 and 120 min time points and early 
effects would therefore, have been obscured. In all of the 
monkeys tested in the present study some recovery of feed- 
ing has already occurred by the 15 min time point and only 
the period between 0 and 20 minutes provided sensitive in- 
formation about the threshold effects of  CCK-8. 
When a dose of CCK-8, sufficient to transiently terminate 
feeding, was used we observed no effect on feeding rate 
either prior to cessation of feeding, or at the time feeding 
resumed. Anika, Houpt and Houpt [1] reported similar ef- 
fects on feeding behavior in pigs, however, their doses were 
probably higher than those we have found to be effective in 
monkeys. 
Our data indicated an extremely rapid and transient time 
course for the effect of intravenous CCK-8, and support the 
Gibbs and associated [6] observation that most effects do not 
extend beyond 15 min after CCK infusion in monkeys. The 
present data contrast, however, with their finding that mon- 
keys do not compensate for early decreases in food intake 
following short term CCK administration [6]. However,  it 
should be noted that Gibbs, Falasco and McHugh infused 
impure CCK, in contrast to the synthetic CCK-8 used in this 
study. Since practical clinical value may depend upon a re- 
sidual effect of CCK-8, we looked carefully at the entire 8 hr 
feeding pattern rates, and intake amounts across time, and 
total intake on the test day compared to preceding and suc- 
ceeding days. By 3 hrs post CCK-8 infusion total cumulative 
intake for the day had returned to control levels indicating 
that the lean monkeys compensated well for the early and 
transient decrease in food intake. Neither the total intake for 
the day, nor the intake on the following day showed any 
effect of  the CCK dose. This contrasts with the report of a 
residual CCK effect observed over days in man [11], but is 
similar to H saiso's finding of an absence of  prolonged effects 
of CCK in rats [9]. 
This rapid and transient effect of CCK-8 on feeding be- 
havior, combined with our finding of early compensation for 
the short term depression of food intake probably accounts 
for the lack of effect of CCK-8 (doses ranging from 1/xg/kg/5 
min to 4 t~g/kg/5 min), on food intake in the baboon following 
an overnight fast [26]. Food intake of the baboon was meas- 
ured over 30 min after the end of a 5 rain CCK infusion. If 
baboons are similar to rhesus monkeys within 10 to 20 min 
following the CCK infusion food intake would have been 
reinitiated, and since normal meal duration probably approx- 
imates 10 min, it is not surprising that no reliable effect of 
CCK on food intake was observed at the 30 min time point 
[26]. 
As we have found in monkeys, Hsiao and others [9] and 
Mueller and Hsiao [21], using similar protocols in rats, 
showed a significant CCK effect on truncating the size of a 
meal, and no effect on rate of  feeding. In both the monkeys 
and rats, the shortened IMI after the truncated first meal 
probably related to the reduced meal size, and not to any 
early disinhibition of feeding. 
As described by Gibbs, Falasco and McHugh [6] and 
Falasco, Smith and Gibbs [3], monkeys showed no signs of 
illness or distress during CCK infusions. Specific observa- 
tion of types of behavior changes elicited during the first 30 
minutes showed the same increase in resting behavior as was 
described by Falasco,  Smith and Gibbs [3]. Whether the de- 
crease in food intake with CCK-8 is related to any mild sen- 
sations of malaise or other non-specific effects of CCK is 
difficult to ascertain. 
Behavioral monitoring of the monkeys suggested that 
under the free feeding conditions at the largest dose, CCK-8 
produced significantly more resting behavior compared to 
saline. That this might be related to the combination of CCK 
plus pregastric factors was suggested by the finding that be- 
havior during the CCK plus intragastric meal infusion did not 
differ from saline plus the intragastric meal. Thus some pre- 
gastric stimuli may be necessary for the CCK-associated sa- 
tiety behavior to occur. Antin, Gibbs and Smith [2], and 
Kraly and others [12] using sham-fed rats found a synergism 
between CCK and pregastric factors, suggesting com- 
plementary roles in producing satiety behavior. 
In the present studies, the rise of plasma glucose during 
the course of ingestion or infusion of a mixed meal was sig- 
nificantly delayed during CCK-8 infusions, but total glucose 
response in the post infusion period was unaffected by the 
preceding CCK. Using intraperitoneal CCK-8 doses five 
times higher than our largest cumulative intravenous dose, 
McLaughlin and Baile [18] found decreased glucose re- 
sponse to a meal for at least 60 minutes in obese and lean 
rats. With doses 1.5 to six times greater than ours, Woods 
and Stein [26] found that CCK-8 reliably attenuated the glu- 
cose response to the subsequent meal at the time point 30 
min after the start of the meal. The highest dose used for our 
monkeys also showed significant suppression of the glucose 
response. Our data show, however, that this is a dose de- 
pendent delay, and not an attenuation of response since the 
integrated glucose area or incremental area calculated to 120 
min was normal except for the highest dose where glucose 
had not yet returned to basal levels at the 120 min time point. 
In light of Moran and McHugh's  demonstration (using ap- 
proximately 1/10 of our CCK-8 dose) that CCK-8 consis- 
tently produced rapid and transient delay or slowing of gas- 
tric emptying [20], a possible explanation is that the dose- 
related delay in plasma glucose response to a mixed meal is a 
direct function of the slowed gastric emptying. 
The doses of CCK used in these experiments were con- 
siderably larger than those producing contraction of the gall 
bladder in humans and baboons [13], and the observed ef- 
fects of CCK-8 are, therefore, possibly pharmacological. Al- 
though the physiological role of CCK in appetite regulation is 
open to question at least until postprandial plasma CCK 
levels can be ascertained and its release from intestinal sites 
selectively inhibited, it may very well act in concert with 
other satiety-affecting factors. Its apparent short time course 
of action, the occurrence of gastrointestinal side effects at 
high doses, the decreased sensitivity of obese Zucker rats to 
its satiety effect [16] and possible habituation over time [19] 
may limit the therapeutic potential as an appetite suppres- 
sant. 
Our studies of intravenous CCK-8 effects on plasma insu- 
lin and glucagon levels in awake, mixed meal-stimulated 
monkeys differs from the effects observed by Rouiller and 
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associates [23] in anesthetized dogs. Infusing CCK-8 over a 
longer period, but at a dose rate equivalent to 30 ng/kg/min, 
they reported significant and rapid (within 5 min) rises in 
plasma insulin and glucagon, with incremental values signifi- 
cantly higher than for saline controls [23]. One might expect 
that the superimposing of a mixed meal on top of the CCK-8 
infusion would produce at least as rapid and significant a rise 
in insulin as was observed for CCK-8 alone in the 
anesthetized dog. This was clearly not true for our monkeys 
where the rise in plasma insulin was significantly delayed 
(more than 15 minutes) by the CCK-8 infusion at all doses 
larger than 15 ng/kg/min. 
Frame and associates [5] have proposed that CCK stimu- 
lates the "quick release" pool of insulin, however, the doses 
of CCK used in our monkeys failed to produce this effect. 
Instead, our data are in accord with the findings of Jensen 
and others [10] using the isolated perfused porcine pancreas, 
in that CCK-8 did not significantly stimulate the secretion of 
insulin. 
CCK may stimulate glucagon release, but the effect is 
small. Neither the mixed meal nor the intravenous CCK 
produced a significant change in plasma glucagon levels, al- 
though comparisons to saline controls suggested some vari- 
able increases. This again, contrasts with the immediate 
large stimulation of glucagon release during CCK-8 infusions 
in the anesthetized dog [23]. Species and protocol differ- 
ences, including differences in time points for response 
measurement, the type and molecular form of the CCK used 
and CCK dose all confound the interpretation of these di- 
verse findings. 
Lonovics et al. [15] have shown in dogs that CCK-8 
produced an effect on plasma levels of pancreatic polypep- 
tide similar to the effect of ingestion of a mixed meal, and 
have suggested that CCK may be an important mediator of 
PP release. Our results suggest that exogenous CCK may 
produce a small additive effect on the PP response to a mixed 
meal. Although variability prevented the finding of signifi- 
cant enhancement by CCK, PP was consistently higher dur- 
ing CCK infusion with a mixed meal when compared to 
saline infusion. Even where there was a probable delay in 
test meal absorption as indicated by the delay in plasma 
glucose rise, pancreatic polypeptide showed an early rise 
and remained above control levels. There was, however, no 
observable dose-response relationship. 
In summary, intravenous CCK-8 infused during the first 6 
min of an oral or intragastric mixed meal in monkeys 
produced significant dose related inhibition of feeding behav- 
ior, delayed but did not otherwise alter the plasma glucose 
and insulin responses, variably enhanced (not significantly) 
the release of glucagon and pancreatic polypeptide, and had 
no effects extending beyond 3 hours. Despite the consistent 
delays in plasma glucose and insulin responses to a mixed 
meal at all CCK-8 infusion rates greater than 15 ng/kg/min, 
the minimal effective dose for feeding inhibition varied from 
30 to 120 ng/kg/min in the same monkeys. This finding 
suggests that the CCK-induced delays in plasma insulin and 
glucose response are not sufficient to the feeding effect. 
Clearly, insulin did not mediate the CCK-8-induced decre- 
ment in food intake, although delay of the early insulin re- 
sponse to a meal may be necessary to the effect on feeding. 
The usual close relationship between plasma glucose and 
insulin levels in response to a mixed meal was not signifi- 
cantly changed by the administration of intravenous CCK. 
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